PMC:7600245 / 11841-12119
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T40 | 91-99 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T106 | 7-8 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T107 | 34-39 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T108 | 240-242 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T108 | 34-39 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T109 | 222-227 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T110 | 272-277 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T87 | 0-278 | Sentence | denotes | Later, a phase 3 randomized, open-label trial in adults (n = 397) hospitalized with severe COVID-19 sponsored by Gilead revealed that the time to clinical improvement for 50% of patients was 10 days in the 5-day treatment group relative to 11 days in the 10-day treatment group. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 292 | 178-186 | Species | denotes | patients | Tax:9606 |
| 321 | 91-99 | Disease | denotes | COVID-19 | MESH:C000657245 |